Atreaon Obtains $8,000,000 New Financing

  • Feed Type
  • Date
    10/26/2011
  • Company Name
    Atreaon
  • Mailing Address
    1188 Centre St Newton Centre, MA 02459
  • Company Description
    The company has developed a synthetic version of the protein, called Atsttrin, and founded Atreaon to commercialize it as a treatment for arthritis.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed